Increased corneal sub‐basal nerve density in patients with Sjögren syndrome treated with topical cyclosporine A

Abstract

Topical CsA led to an increase in corneal SBN density, improving clinical signs and symptoms of SSDE. Our results also suggest an improved response to treatment in patients with less initial nerve damage.